+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ibutamoren"

Turner Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Turner Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H2 2020 - Product Thumbnail Image

Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 87 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Ibutamoren is a drug used to treat endocrine and metabolic disorders. It is a growth hormone secretagogue, meaning it stimulates the release of growth hormone from the pituitary gland. It is used to treat growth hormone deficiency, as well as other conditions such as Turner Syndrome, Prader-Willi Syndrome, and short stature due to Noonan Syndrome. Ibutamoren is also used to treat age-related muscle wasting and osteoporosis. It is available in both oral and injectable forms. Ibutamoren is a relatively new drug, and the market is still developing. It is becoming increasingly popular as a treatment for endocrine and metabolic disorders, due to its effectiveness and safety profile. It is also being studied for its potential to treat other conditions, such as obesity and type 2 diabetes. Some companies in the Ibutamoren market include Novo Nordisk, Pfizer, and Eli Lilly. Show Less Read more